These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11324469)

  • 1. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells.
    Zhang XW; Jiang JF; Xu B
    Acta Pharmacol Sin; 2000 Apr; 21(4):364-8. PubMed ID: 11324469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of human hepatoma Hep G2 cells induced by 10-hydroxycamptothecin.
    Zhang X; Zhou Y; Xu B
    Chin Med J (Engl); 2000 Aug; 113(8):712-3. PubMed ID: 11776054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells.
    Zhang XW; Xu B
    Anticancer Drugs; 2000 Oct; 11(9):747-56. PubMed ID: 11129738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
    Zhang XW; Qing C; Xu B
    Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
    Hsu YL; Kuo PL; Chiang LC; Lin CC
    Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
    Chai LP; Su ZZ; Xian ZX
    Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between lactone ring forms of HCPT and their antitumor activities.
    Zhou JJ; Liu J; Xu B
    Acta Pharmacol Sin; 2001 Sep; 22(9):827-30. PubMed ID: 11749865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hydroxycamptothecin on apoptosis-inducing factor (AIF) expression and on AIF translocation in human hepatocellular cancer cell SMMC-7721].
    Fu YR; Qiu ZY; Yan YR
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):285-8. PubMed ID: 16635299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
    Zhang RG; Wang XW; Yuan JH; Xie H
    Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
    Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
    Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
    Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
    Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.
    Zhang Y; Song WJ; Zhang FQ; Liu WH; Dou KF
    Dig Dis Sci; 2011 Aug; 56(8):2473-81. PubMed ID: 21318586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines.
    te Poele RH; Joel SP
    Br J Cancer; 1999 Dec; 81(8):1285-93. PubMed ID: 10604724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
    Ng LT; Chiang LC; Lin YT; Lin CC
    Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expression.
    Hsieh TJ; Liu TZ; Chern CL; Tsao DA; Lu FJ; Syu YH; Hsieh PY; Hu HS; Chang TT; Chen CH
    Food Chem Toxicol; 2005 Jul; 43(7):1117-26. PubMed ID: 15833387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with Rhizoma Paridis and Rhizoma Curcuma longa extracts and 10-hydroxycamptothecin enhances the antitumor effect in H22 tumor model by increasing the plasma concentration.
    Liu Z; Li H; Fan Y; Liu Y; Man S; Yu P; Gao W
    Biomed Pharmacother; 2016 Oct; 83():627-634. PubMed ID: 27459119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.